Esperion recalls

Esperion appears in 2 official U.S. recall notices indexed by RecallRadar, most recently on 2024-04-24.

Company names are normalized from agency data (legal suffixes removed), so related firms may appear under separate pages.

• NEXLIZET (bempedoic acid and ezetimibe) tablets, 180 mg/10 mg, 30-count bottle, Rx only, Manufactured for: Esperion Therapeutics, Ann Arbor…
  FDA Drug · Class III · 2024-04-24 · Esperion
• Nexlizet (bempedoic acid and ezetimibe), 180ng/18mg, 30 tablets, Rx only, Manufactured for: Esperion Therapeutics, Inc, Ann Arbor, MI 48108…
  FDA Drug · Class III · 2023-09-13 · Esperion